Search

You searched for "imaging"

878 results found

Urology Week 2024

23 September 2024 -29 September 2024
Continence health problems are a major health issue impacting not only patients but their loved ones, national health systems, the economy, the environment, and society. Urology Week 2024 focuses on incontinence to help raise awareness. Learn more by exploring this website. Let’s spread the word!

Neuromodulation for lower urinary tract dysfunction – an ICS update

1 July 2018 | | URO - Functional / Reconstructive Urology, URO - Technology
Non-invasive and invasive electro-stimulation techniques have been extensively studied in the treatment of lower urinary tract and bowel dysfunction, including overactive bladder syndrome (OAB), non-obstructive chronic urinary retention, faecal incontinence and chronic pelvic pain. Currently, the most common indication for...
The Journal of Urology image.

Assessing resolution of isolated hydronephrosis – is APPD superior to the SFU system?

14 April 2021 | | URO - Paediatrics
Antenatal scanning detects urinary tract dilatation in 1-5% of pregnancies. Isolated hydronephrosis (i.e., that not due to secondary dilatation e.g. bladder dysfunction) is known to resolve or improve in most; some patients may, however, require intervention through deterioration of obstruction...

Urology around the world: An overview of healthcare in Germany

7 November 2024 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatrics, URO - Core Urology, URO - Functional / Reconstructive Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Germany boasts a highly developed and comprehensive healthcare system, renowned for its quality and accessibility. The urology landscape in the country mirrors this overall excellence, characterised by a well-structured network of specialists, advanced technology, and a strong emphasis on patient-centered...

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | URO - Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...

Priapism

7 January 2021 | | URO - Andrology
Priapism is defined as an abnormally persistent erection lasting greater than four hours, not associated with sexual desire [1]. Although relatively uncommon with an incidence of 1.5 per 100,000 [2], priapism has a risk of complications which can have a...

Things I wish I knew before starting on-call as an CST in urology

4 March 2026 | | URO - Core Urology
When I started my first core surgical trainee (CST) job in urology, I had no prior exposure or experience. Quickly I realised the significant step up and responsibility involved. Covering multiple sites overnight is something that requires organisation and awareness...

medac Pharma launch education platform, medac Academy

8 April 2022 | Research & Development, Company Profiles
medac Pharma have launched a new digital education platform for UK healthcare professionals, medac Academy.

New techniques in UTI diagnosis

12 September 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
Urinary tract infection (UTI) is a common reason for seeking medical care in both primary and secondary settings. Half of women will have at least one episode of cystitis in their lifetime, and a third of them will have experienced...

Bupa covers accurate PSE prostate cancer blood test

9 April 2025 | Contracts & Distributors, Research & Development
A new era in prostate cancer detection is emerging with the EpiSwitch® PSE blood test, a highly accurate tool that enhances early diagnosis while significantly cutting false positives. Now covered by Bupa as a pre-biopsy test, PSE has demonstrated 94%...

Can the latest patient decision aid help OAB patients?

8 January 2025 | | URO - Functional / Reconstructive Urology
OAB Answers is a patient decision aid co-authored by several European urologists and gynaecologists, and two patient advocates, to help patients understand and manage their overactive bladder (OAB). It is a 36-page document split into several clear sections, aiming to...

Introducing Caress Flow, a painless, effective, and affordable treatment for intimate health

14 November 2024 | Company Profiles, Research & Development
Caress Flow, a groundbreaking treatment that promises to transform the management of vaginal pathologies, is now available in the UK. The innovative therapy offers a holistic, painless solution to a range of vaginal symptoms, with clinical evidence demonstrating significant benefits,...